SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-23-006510
Filing Date
2023-09-18
Accepted
2023-09-18 08:01:30
Documents
13
Period of Report
2023-09-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT intlstemcell_8k.htm   iXBRL 8-K 29557
2 FORM OF NOTE ISSUED ON SEPTEMBER 15, 2023 intlstemcell_ex1001.htm EX-10.1 14970
  Complete submission text file 0001683168-23-006510.txt   215285

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE isco-20230915.xsd EX-101.SCH 3054
4 XBRL LABEL FILE isco-20230915_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE isco-20230915_pre.xml EX-101.PRE 22385
7 EXTRACTED XBRL INSTANCE DOCUMENT intlstemcell_8k_htm.xml XML 2942
Mailing Address 5950 PRIESTLY DRIVE CARLSBAD CA 92008
Business Address 5950 PRIESTLY DRIVE CARLSBAD CA 92008 760-940-6383
International Stem Cell CORP (Filer) CIK: 0001355790 (see all company filings)

IRS No.: 204494098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51891 | Film No.: 231260134
SIC: 2834 Pharmaceutical Preparations